Am. J. Respir. Crit. Care Med., Volume 158, Number 5, November 1998, 1626-1635

Morphometric Analysis of Insulin-like Growth Factor-I Localization in Lung Tissues of Patients with Idiopathic Pulmonary Fibrosis

SOO-TAEK UH, YOSHIKAZU INOUE, TALMADGE E. KING Jr., EDWARD D. CHAN, LEE S. NEWMAN, and DAVID W. H. RICHES

Departments of Pediatrics and Medicine, National Jewish Medical and Research Center; and Departments of Biochemistry and Molecular Genetics, Pharmacology, and Immunology, and Division of Pulmonary Sciences and Critical Care Medicine, University of Colorado Health Sciences Center, Denver, Colorado

Insulin-like growth factor-I (IGF-I) has been implicated in the pathogenesis of idiopathic pulmonary fibrosis (IPF) through its ability to stimulate fibroblast proliferation and collagen synthesis. However, although alveolar macrophages (AM) have been shown to express this growth factor, it is likely to also have other cellular sources. We sought to determine the distribution of cells expressing IGF-I in lung tissues obtained from 10 patients with IPF and 10 control subjects. We evaluated the levels of IGF-I and of a macrophage/monocyte-specific marker, CD68, by immunocytochemistry and quantified by morphometry. In control subjects, IGF-I was localized principally to AM. In contrast, in IPF patients IGF-I was localized to AM, interstitial macrophages, alveolar epithelial cells, and ciliated columnar epithelial cells. The normalized volume density (Vv) of IGF-I-positive (IGF-I⁺) interstitial macrophages (Vv of IGF-I⁺ interstitial macrophages/Vv of lung × 100) was increased in patients with IPF as compared with control subjects, and the ratio of Vv of IGF-I⁺ to CD68⁺ interstitial macrophages correlated with: (1) the degree of clinical impairment in patients with IPF as measured by their clinical-radiologic-physiologic (CRP) score; and (2) the degree of collagen deposition in the interstitium. These findings support a role for interstitial macrophages as a source of IGF-I in IPF.

This article has been cited by other articles:

				M. P. Keane The role of chemokines and cytokines in lung fibrosis Eur. Respir. Rev., December 1, 2008; 17(109): 151 - 156. [Abstract] [Full Text] [PDF]

				A.-M. Pulichino, I-M. Wang, A. Caron, J. Mortimer, A. Auger, Y. Boie, J. A. Elias, A. Kartono, L. Xu, J. Menetski, et al. Identification of Transforming Growth Factor {beta}1-Driven Genetic Programs of Acute Lung Fibrosis Am. J. Respir. Cell Mol. Biol., September 1, 2008; 39(3): 324 - 336. [Abstract] [Full Text] [PDF]

				R. Eferl, P. Hasselblatt, M. Rath, H. Popper, R. Zenz, V. Komnenovic, M.-H. Idarraga, L. Kenner, and E. F. Wagner Development of pulmonary fibrosis through a pathway involving the transcription factor Fra-2/AP-1 PNAS, July 29, 2008; 105(30): 10525 - 10530. [Abstract] [Full Text] [PDF]

				A. L. Mora, E. Torres-Gonzalez, M. Rojas, C. Corredor, J. Ritzenthaler, J. Xu, J. Roman, K. Brigham, and A. Stecenko Activation of Alveolar Macrophages via the Alternative Pathway in Herpesvirus-Induced Lung Fibrosis Am. J. Respir. Cell Mol. Biol., October 1, 2006; 35(4): 466 - 473. [Abstract] [Full Text] [PDF]

				S. D. Oldroyd, Y. Miyamoto, A. Moir, T. S. Johnson, A. M. El Nahas, and J. L. Haylor An IGF-I antagonist does not inhibit renal fibrosis in the rat following subtotal nephrectomy Am J Physiol Renal Physiol, March 1, 2006; 290(3): F695 - F702. [Abstract] [Full Text] [PDF]

				P. G. Woodruff, L. L. Koth, Y. H. Yang, M. W. Rodriguez, S. Favoreto, G. M. Dolganov, A. C. Paquet, and D. J. Erle A Distinctive Alveolar Macrophage Activation State Induced by Cigarette Smoking Am. J. Respir. Crit. Care Med., December 1, 2005; 172(11): 1383 - 1392. [Abstract] [Full Text] [PDF]

				M. W. Wynes and D. W. H. Riches Transcription of macrophage IGF-I exon 1 is positively regulated by the 5'-untranslated region and negatively regulated by the 5'-flanking region Am J Physiol Lung Cell Mol Physiol, June 1, 2005; 288(6): L1089 - L1098. [Abstract] [Full Text] [PDF]

				C. A. Feghali-Bostwick IGF-I: mediator of fibrosis or carcinogenesis? Am J Physiol Lung Cell Mol Physiol, May 1, 2005; 288(5): L803 - L804. [Full Text] [PDF]

				S. K. Frankel, B. M. Moats-Staats, C. D. Cool, M. W. Wynes, A. D. Stiles, and D. W. H. Riches Human insulin-like growth factor-IA expression in transgenic mice promotes adenomatous hyperplasia but not pulmonary fibrosis Am J Physiol Lung Cell Mol Physiol, May 1, 2005; 288(5): L805 - L812. [Abstract] [Full Text] [PDF]

				M. M. Kelly, R. Leigh, P. Bonniaud, R. Ellis, J. Wattie, M. J. Smith, G. Martin, M. Panju, M. D. Inman, and J. Gauldie Epithelial Expression of Profibrotic Mediators in a Model of Allergen-Induced Airway Remodeling Am. J. Respir. Cell Mol. Biol., February 1, 2005; 32(2): 99 - 107. [Abstract] [Full Text] [PDF]

				J. M. Pilewski, L. Liu, A. C. Henry, A. V. Knauer, and C. A. Feghali-Bostwick Insulin-Like Growth Factor Binding Proteins 3 and 5 Are Overexpressed in Idiopathic Pulmonary Fibrosis and Contribute to Extracellular Matrix Deposition Am. J. Pathol., February 1, 2005; 166(2): 399 - 407. [Abstract] [Full Text] [PDF]

				M. W. Wynes, S. K. Frankel, and D. W. H. Riches IL-4-induced macrophage-derived IGF-I protects myofibroblasts from apoptosis following growth factor withdrawal J. Leukoc. Biol., November 1, 2004; 76(5): 1019 - 1027. [Abstract] [Full Text] [PDF]

				J. A. Belperio, M. Dy, L. Murray, M. D. Burdick, Y. Y. Xue, R. M. Strieter, and M. P. Keane The Role of the Th2 CC Chemokine Ligand CCL17 in Pulmonary Fibrosis J. Immunol., October 1, 2004; 173(7): 4692 - 4698. [Abstract] [Full Text] [PDF]

				N. Khalil and R. O'Connor Idiopathic pulmonary fibrosis: current understanding of the pathogenesis and the status of treatment Can. Med. Assoc. J., July 20, 2004; 171(2): 153 - 160. [Abstract] [Full Text] [PDF]

				M. W. Wynes and D. W. H. Riches Induction of Macrophage Insulin-Like Growth Factor-I Expression by the Th2 Cytokines IL-4 and IL-13 J. Immunol., October 1, 2003; 171(7): 3550 - 3559. [Abstract] [Full Text] [PDF]

				Y. D. Xu, J. Hua, A. Mui, R. O'Connor, G. Grotendorst, and N. Khalil Release of biologically active TGF-{beta}1 by alveolar epithelial cells results in pulmonary fibrosis Am J Physiol Lung Cell Mol Physiol, September 1, 2003; 285(3): L527 - L539. [Abstract] [Full Text] [PDF]

				P. M. Krein, P. J. B. Sabatini, W. Tinmouth, F. H. Y. Green, and B. W. Winston Localization of Insulin-like Growth Factor-I in Lung Tissues of Patients with Fibroproliferative Acute Respiratory Distress Syndrome Am. J. Respir. Crit. Care Med., January 1, 2003; 167(1): 83 - 90. [Abstract] [Full Text] [PDF]

				P. M. Krein and B. W. Winston Roles for Insulin-Like Growth Factor I and Transforming Growth Factor-{beta} in Fibrotic Lung Disease Chest, December 1, 2002; 122(6_suppl): 289S - 293S. [Abstract] [Full Text] [PDF]

				F. H.Y. Green Overview of Pulmonary Fibrosis Chest, December 1, 2002; 122(6_suppl): 334S - 339S. [Abstract] [Full Text] [PDF]

				Y. Inoue, T. E. King Jr., E. Barker, E. Daniloff, and L. S. Newman Basic Fibroblast Growth Factor and Its Receptors in Idiopathic Pulmonary Fibrosis and Lymphangioleiomyomatosis Am. J. Respir. Crit. Care Med., September 1, 2002; 166(5): 765 - 773. [Abstract] [Full Text] [PDF]

				A E Currie, M Kelly, J R Vyas, H Pandya, D Field, and S Kotecha Fibroblast mitogenic activity of lung lavage fluid from infants with chronic lung disease of prematurity Arch. Dis. Child. Fetal Neonatal Ed., May 1, 2002; 86(3): F193 - F197. [Abstract] [Full Text] [PDF]

				C. A. BLOOR, R. A. KNIGHT, R. K. KEDIA, M. A. SPITERI, and J. T. ALLEN Differential mRNA Expression of Insulin-like Growth Factor-1 Splice Variants in Patients With Idiopathic Pulmonary Fibrosis and Pulmonary Sarcoidosis Am. J. Respir. Crit. Care Med., July 15, 2001; 164(2): 265 - 272. [Abstract] [Full Text] [PDF]